Definitive Healthcare Valuation

DH Stock  USD 2.97  0.16  5.69%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Definitive Healthcare shows a prevailing Real Value of $3.43 per share. The current price of the firm is $2.97. Our model computes the value of Definitive Healthcare from reviewing the firm fundamentals such as Profit Margin of (1.64) %, current valuation of 280.23 M, and Shares Outstanding of 112.91 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Definitive Healthcare's valuation include:
Price Book
0.714
Enterprise Value
280.2 M
Enterprise Value Ebitda
46.6922
Price Sales
1.258
Forward PE
13.3869
Undervalued
Today
2.97
Please note that Definitive Healthcare's price fluctuation is very risky at this time. Calculation of the real value of Definitive Healthcare is based on 3 months time horizon. Increasing Definitive Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Definitive Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Definitive Stock. However, Definitive Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.97 Real  3.43 Target  5.25 Hype  2.79
The intrinsic value of Definitive Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Definitive Healthcare's stock price.
3.43
Real Value
9.40
Upside
Estimating the potential upside or downside of Definitive Healthcare Corp helps investors to forecast how Definitive stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Definitive Healthcare more accurately as focusing exclusively on Definitive Healthcare's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.020.020.04
Details
Hype
Prediction
LowEstimatedHigh
0.142.798.76
Details
14 Analysts
Consensus
LowTarget PriceHigh
4.785.255.83
Details
When choosing an evaluation method for Definitive Healthcare, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.

Definitive Healthcare Cash

147.43 Million

Definitive Valuation Trend

Definitive Healthcare's real value analysis enables investors to forecast the earnings more efficiently. Using both Definitive Healthcare's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.

Definitive Revenue by Product

Definitive Healthcare Total Value Analysis

Definitive Healthcare Corp is currently forecasted to have takeover value of 280.23 M with market capitalization of 317.28 M, debt of 9.99 M, and cash on hands of 347.87 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Definitive Healthcare fundamentals before making investment evaluation based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
280.23 M
317.28 M
9.99 M
347.87 M

Definitive Healthcare Investor Information

About 95.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 3.54. The firm had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Definitive Healthcare's historical financial statements, Definitive Healthcare Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities37.6 M58.2 M
Way Down
Slightly volatile

Definitive Healthcare Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Definitive signifies not a very effective usage of assets in March.
 
Covid

Definitive Healthcare Ownership Allocation

Definitive Healthcare holds a total of 112.91 Million outstanding shares. The majority of Definitive Healthcare Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Definitive Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Definitive Healthcare. Please pay attention to any change in the institutional holdings of Definitive Healthcare Corp as this could imply that something significant has changed or is about to change at the company. Also note that almost two million thirty-two thousand three hundred ninety-eight invesors are currently shorting Definitive Healthcare expressing very little confidence in its future performance.

Definitive Healthcare Profitability Analysis

The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 211.52 M.

About Definitive Healthcare Valuation

An absolute valuation paradigm, as applied to Definitive Stock, attempts to find the value of Definitive Healthcare based on its fundamental and basic technical indicators. By analyzing Definitive Healthcare's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Definitive Healthcare's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Definitive Healthcare. We calculate exposure to Definitive Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Definitive Healthcare's related companies.
Last ReportedProjected for Next Year
Gross Profit197.5 M153.5 M
Pretax Profit Margin(2.51)(2.39)
Operating Profit Margin(2.82)(2.68)
Net Loss(1.64)(1.56)
Gross Profit Margin 0.78  0.58 

Definitive Healthcare Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding116.6 M
Forward Price Earnings13.3869

Definitive Healthcare Current Valuation Indicators

Valuation refers to the process of determining the present value of Definitive Healthcare Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Definitive we look at many different elements of the entity such as Definitive's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Definitive Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Definitive Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Definitive Healthcare's worth.

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm